[{"notes_id":"1_2674","category":"3","subcategory":"1","title":"Diabetes mellitus (type 1): diagnosis","body":"The symptoms and signs in a new diagnosis of type 1 diabetes mellitus (T1DM) are typically those seen in diabetic ketoacidosis although the diagnosis is usually over a longer time frame.<br \/><br \/>Features of diabetic ketoacidosis (DKA)<br \/><ul><li>abdominal pain<\/li><li>polyuria, polydipsia, dehydration<\/li><li>Kussmaul respiration (deep hyperventilation)<\/li><li>acetone-smelling breath ('pear drops' smell)<\/li><\/ul><br \/>Investigations<br \/><ul><li>urine should be dipped for glucose and ketones<\/li><li>fasting glucose and random glucose (see below for diagnostic thresholds)<\/li><li><span class=\"concept\" data-cid=\"4324\">HbA1c is not as useful for patients with a possible or suspected diagnosis of T1DM<\/span> as it may not accurately reflect a recent rapid rise in serum glucose<\/li><li><span class=\"concept\" data-cid=\"11136\">C-peptide levels are typically low<\/span> in patients with T1DM<\/li><li><span class=\"concept\" data-cid=\"11137\">diabetes-specific autoantibodies<\/span> are useful to distinguish between type 1 and type 2 diabetes (see below)<\/li><\/ul><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Antibody<\/th><th>Notes<\/th><\/tr><\/thead><tbody><tr><td>Antibodies to glutamic acid decarboxylase (anti-GAD)<\/td><td>Present in around 80% of patients with T1DM<\/td><\/tr><tr><td>Islet cell antibodies (ICA, against cytoplasmic proteins in the beta cell)<\/td><td>Present in around 70-80% of patients with T1DM<\/td><\/tr><tr><td>Insulin autoantibodies (IAA)<\/td><td>Presence in T1DM correlates strongly with age, found in over 90% of young children with T1DM but only 60% of older patients<\/td><\/tr><tr><td>Insulinoma-associated-2 autoantibodies (IA-2A)<\/td><td><\/td><\/tr><\/tbody><\/table><\/div><br \/><br \/><h5 class='notes-heading'>Diagnostic criteria for type 1 diabetes mellitus<\/h5><br \/>If the patient is symptomatic:<br \/><ul><li>fasting glucose greater than or equal to 7.0 mmol\/l<\/li><li>random glucose greater than or equal to 11.1 mmol\/l (or after 75g oral glucose tolerance test)<\/li><\/ul><br \/>If the patient is asymptomatic the above criteria apply but must be demonstrated on two separate occasions.<br \/><br \/><br \/><h5 class='notes-heading'>Distinguishing between type 1 and type 2 diabetes meliitus<\/h5><br \/>The major differences are shown in the table below:<br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><\/th><th>Type 1 diabetes<\/th><th>Type 2 diabetes<\/th><\/tr><\/thead><tbody><tr><td><b>Age of onset<\/b><\/td><td>Typically < 20 years<br \/><ul><li>however, 40% > 30 years<\/td><td>Typically > 40 years<\/li><li>however, may occur in younger, obese patients<\/td><\/tr><tr><td><\/li><\/ul><b>Speed of onset<\/b><\/td><td>More acute, hours-days<\/td><td>Slower, weeks-months<\/td><\/tr><tr><td><b>Weight of patient<\/b><\/td><td>Recent weight loss typical<\/td><td>Obesity is strong risk factor and recent weight loss is rare<\/td><\/tr><tr><td><b>Features<\/b><\/td><td>Features of DKA as above<\/td><td>Milder symptoms e.g. polyuria, polydipsia<\/td><\/tr><tr><td><b>Ketonuria<\/b><\/td><td>Common<\/td><td>Rare<\/td><\/tr><\/tbody><\/table><\/div><br \/>NICE state the following:<br \/><br \/><div class='bs-callout bs-callout-default'><i><br \/>Diagnose type 1 diabetes on clinical grounds in adults presenting with hyperglycaemia, bearing in mind that people with type 1 diabetes typically (but not always) have one or more of:<br \/><ul><li>ketosis<\/li><li>rapid weight loss<\/li><li>age of onset below 50 years<\/li><li>BMI below 25 kg\/m\u00b2<\/li><li>personal and\/or family history of autoimmune disease<\/li><\/ul><\/i><\/div><br \/>In terms of diagnosing T1DM, NICE recommend the following on who may need further tests: <br \/><br \/><div class='bs-callout bs-callout-default'><i><br \/>Consider further investigation in adults that involves measurement of C-peptide and\/or diabetes-specific autoantibody titres if:<br \/><ul><li>type 1 diabetes is suspected but the clinical presentation includes some <span class=\"concept\" data-cid=\"11139\">atypical features (for example, age 50 years or above, BMI of 25 kg\/m\u00b2 or above, slow evolution of hyperglycaemia or long prodrome)<\/span> <\/li><\/ul><\/i><\/div><br \/>Conversely, for patients suspected of type 2 diabetes, <span class=\"concept\" data-cid=\"11138\">if they over the age of 40 years and respond well to oral hypoglycaemic agents do not need to undergo further testing<\/span> for type 1 diabetes. For those in whom there is a doubt, <span class=\"concept\" data-cid=\"11137\">C-peptide levels and diabetes-specific autoantibodies are the investigations of choice<\/span>.<br \/><br \/>Example scenarios<br \/><ul><li>a 15-year-old presents with weight loss, lethargy. Ketones and glucose found in the urine. A random serum glucose is 14 mmol\/L &rarr; T1DM, no need for further investigations<\/li><li>a 38-year-old obese man presents with polyuria. A random glucose is 12.5 mmol\/L &rarr; Intermediate age for T1DM\/T2DM, a risk factor for T2DM (obesity) but not clear cut - do C-peptide levels and diabetes-specific autoantibodies<\/li><li>a 52-year-old woman (body mass index 23 kg\/m\u00b2) presents with polyuria and polydipsia. Ketones are present in the urine &rarr; age atypical for T1DM but other features consistent - do C-peptide levels and diabetes-specific autoantibodies<\/li><li>a 59-year-old obese man presents with polyuria. A random serum glucose is 12.0 mmol\/L &rarr; T2DM, no need for further investigations<\/li><\/ul>","notes_hash":"f9d4cc9011d3a97e05e1adb5884ae68e","knowledge_graph_node_id_link":1224,"links":"","media":"","concepts_for_notes":{"11136":{"concept_text":"C-peptide levels are typically low in patients with T1DM","concept_percentile":"85"},"11137":{"concept_text":"C-peptide levels and diabetes-specific autoantibodies are useful to distinguish between type 1 and type 2 diabetes","concept_percentile":"86"}},"category_name":"Endocrinology \/ Metabolic","subcategory_name":"Endocrinology","comment_count":2},"",[]]